About AbbVie Inc.
AbbVie is a biopharmaceutical company that develops and sells medicines for serious and long-term conditions. Its focus areas include immune disorders, cancer, neuroscience, eye care, and aesthetics, and its main products include Humira, Skyrizi, Rinvoq, Imbruvica, and Botox. Most of its revenue comes from branded prescription drugs, with an aesthetics business built on products such as Botox Cosmetic and Juvederm. Robert Michael serves as chief executive, and the company is based in North Chicago, Illinois. AbbVie was created in 2013 when it separated from Abbott, and it runs as a single global business focused on developing and selling medicines.
A sourced map of AbbVie Inc.'s relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on AbbVie Inc. and the wider market, hosted by our team, will appear here once episodes are live.